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In Brief
Oosterhof et al. show that colony-
stimulating factor 1 receptor (CSF1R)
primarily regulates microglia density and
not their normal differentiation. In
addition, they find widespread depletion
of microglia in CSF1R-haploinsufficient
zebrafish and leukodystrophy patients,
also in the absence of pathology,
indicating that microglia depletion may
contribute to loss of white matter.
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Microglia are brain-resident macrophages with tro-
phic and phagocytic functions. Dominant loss-of-
function mutations in a key microglia regulator, col-
ony-stimulating factor 1 receptor (CSF1R), cause
adult-onset leukoencephalopathy with axonal spher-
oids and pigmented glia (ALSP), a progressive white
matter disorder. Because it remains unclear pre-
cisely how CSF1R mutations affect microglia, we
generated an allelic series of csf1rmutants in zebra-
fish to identify csf1r-dependent microglia changes.
We found that csf1rmutations led to aberrant micro-
glia density and distribution and regional loss of mi-
croglia. The remaining microglia still had a micro-
glia-specific gene expression signature, indicating
that they had differentiated normally. Strikingly, we
also observed lower microglia numbers and wide-
spread microglia depletion in postmortem brain tis-
sue of ALSP patients. Both in zebrafish and in human
disease, local microglia loss also presented in re-
gions without obvious pathology. Together, this im-
plies that CSF1R mainly regulates microglia density
and that early loss of microglia may contribute to
ALSP pathogenesis.
INTRODUCTION
Microglia are specialized brain macrophages whose functions in
the brain include phagocytosis and provision of trophic support
(Paolicelli et al., 2011; Safaiyan et al., 2016; Stevens et al., 2007;
Tremblay et al., 2010; van Ham et al., 2012). Mutations in several
genes that are highly expressed in microglia cause progressive
white matter brain diseases (Meuwissen et al., 2016; PalonevaCell
This is an open access article under the CC BY-Net al., 2002; Prinz and Priller, 2014; Rademakers et al., 2011).
For example, dominant loss-of-function mutations in colony-
stimulating factor 1 receptor (CSF1R) cause adult-onset leu-
koencephalopathy with axonal spheroids and pigmented glia
(ALSP), also known as hereditary diffuse leukoencephalopathy
with axonal spheroids (HDLS) (Konno et al., 2017; Wider et al.,
2009). Even though low expression of Csf1r has been reported
in some neurons in the hippocampus, the expression of
CSF1R is almost exclusive to microglia, suggesting that ALSP
pathogenesis involves microglia dysfunction (Luo et al., 2013).
But where one study showed reduced microglia numbers in
cortical layers 3 and 4 in postmortem end-stage ALSP brain
sections, another showed increased microglia numbers during
earlier ALSP disease stages (Oyanagi et al., 2017; Tada et al.,
2016). Themechanismwhereby heterozygousCSF1Rmutations
affect microglia and, consequently, brain homeostasis is still un-
known. Insight into ALSP pathogenesis will therefore contribute
to our understanding of microglia function in the vertebrate brain
and of microglia involvement in other brain diseases.
Even though CSF1R signal transduction has been studied
extensively in macrophages, it is not entirely clear how defective
CSF1R signaling affects microglia in vivo. Activation by one of
the two CSF1R ligands (CSF-1 or macrophage colony-stimu-
lating factor [M-CSF]) or interleukin 34 (IL-34) leads to auto-
phosphorylation of the tyrosine kinase receptor. In vitro, down-
stream activation of signal transduction pathways regulates the
production, survival, differentiation, and function of macro-
phages (Dai et al., 2002; Erblich et al., 2011; Ginhoux et al.,
2010; Wang et al., 2012). Genetic evidence for the conse-
quences of CSF1R activation in vivo indicates that CSF1R pri-
marily plays a homeostatic role in regulating the viability and pro-
liferation of microglia (Cecchini et al., 1994; Jenkins et al., 2013).
Indeed, genetic deficiency of CSF1R signaling reduces protec-
tion against bacterial infection, mainly by limiting macrophage
supply (Cheers et al., 1989; Paga´n et al., 2015; Teitelbaum
et al., 1999; Wang et al., 2012). In contrast, by showing thatReports 24, 1203–1217, July 31, 2018 ª 2018 The Author(s). 1203
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Csf1r/ macrophage precursors have the same lineage poten-
tial as those in the wild-type, differentiating efficiently into mac-
rophages but failing to form colonies, a recent study concluded
that Csf1r deficiency has little effect on myeloid differentiation
in vivo (Endele et al., 2017).
Loss of Csf1r in mice leads to an almost complete absence of
microglia and also to severe developmental abnormalities and a
shorter lifespan (Dai et al., 2002; Erblich et al., 2011; Ginhoux
et al., 2010). Csf1r/ brains show widened cerebral ventricles,
which is also observed in ALSP patients. Mice lacking microglia
also show cerebrovascular defects and reduced numbers of
oligodendrocyte lineage cells (Erblich et al., 2011; Hagemeyer
et al., 2017; Nandi et al., 2012). In addition, postnatal pharmaco-
logical inhibition of CSF1R in mice reduces the number of oligo-
dendrocytes and oligodendrocyte precursor cells (OPCs) in a
region-dependent manner (Hagemeyer et al., 2017). The latter
effect could predispose to myelination defects later in life.
To understand the effect of CSF1R haploinsufficiency on mi-
croglia, we used the zebrafish as a model organism. Zebrafish
are an upcoming genetic model organism to study brain dis-
eases, including leukoencephalopathies (Zhang et al., 2016).
They are highly suitable for in vivo imaging because they develop
externally and are transparent at early stages (Haud et al., 2011;
Oosterhof et al., 2015; Zhang et al., 2016). Previously, we identi-
fied the zebrafish microglia transcriptome, which shares high
similarity with mouse and humanmicroglia transcriptomes (Gos-
selin et al., 2017; Oosterhof et al., 2017). Zebrafish express two
homologs of human CSF1R: csf1ra and csf1rb. We found that
zebrafish csf1ra mutants show reduced microglia numbers
only during development, partially mimicking mouse mutants.
This suggests that the cellular functions of CSF1R are highly
conserved between species but that zebrafish csf1rb and csf1ra
are likely partially redundant. In the present study we therefore
created an allelic series of zebrafish csf1r loss-of-function mu-
tants in which we observed local loss of microglia, a general
reduction in microglia numbers, and an aberrant distribution of
microglia. Because we found that dysregulation of microglia
density was a primary consequence of csf1r haploinsufficiency,
we next investigated whether CSF1R haploinsufficiency also af-
fects microglia density in postmortem brain tissue of ALSP pa-
tients. This revealed widespread depletion of microglia and a
general reduction in microglia density. In humans and zebrafish
alike, changes in microglia density and distribution in the
absence of obvious myelin pathology implied that loss of micro-
glia may be an early event in ALSP pathogenesis.
RESULTS
Zebrafish Csf1ra and Csf1rb Together Are Functionally
Homologous to Mammalian CSF1R
To study how CSF1R mutations affect microglia and the brain,
we exploited the fact that zebrafish have two homologs for
human CSF1R: Csf1ra and Csf1rb. Both of these are highly
expressed in adult zebrafish microglia (Figure 1A; Oosterhof
et al., 2017). Unlike Csf1r knockout mice, which are almost
completely devoid of microglia, zebrafish with homozygous
loss-of-function mutations only in csf1ra (from here on called
csf1ra/), show reduced microglia numbers only during early1204 Cell Reports 24, 1203–1217, July 31, 2018development (Herbomel et al., 2001). This suggests that csf1rb
and csf1ra share a role in microglia development.
To test this, we introduced a premature stop codon in exon 3
of the csf1rb gene by transcription activator-like effector
nuclease (TALEN)-mediated genome editing and assessed mi-
croglia numbers by neutral red staining (Figures 1B and S1A),
which can be used to label microglia in zebrafish larvae in vivo.
Although the microglia numbers in homozygous csf1rb mutants
were a little lower than in the wild-type, mutants deficient in
both csf1ra and csf1rb (from here on called csf1rDM), were
almost completely devoid of microglia (Figures 1C and 1D).
The absence of microglia in csf1rDM mutants was confirmed in
larval and adult zebrafish by immunostaining for L-plastin (Fig-
ures 1E, 2A, and 2B). Althoughmicroglia were almost completely
absent in csf1rDM, other macrophage populations were still pre-
sent in adult organs, including the skin and the intestine (Fig-
ure S1B). Adult csf1rDM animals were viable and, in-crossmating
of csf1rDM adult animals, produced viable homozygous mutant
offspring (data not shown). However, after around 3 months of
age, mutant animals occasionally showed seizure-like behavior,
and their survival rate was lower than that of wild-type animals
(data not shown). Some csf1rDM brains displayed signs of cere-
bral hemorrhaging that were consistent with the hemorrhages
previously reported in Csf1r/ mice (Erblich et al., 2011). These
data show that zebrafish Csf1ra and Csf1rb both regulate the
development of themicroglia population, and both are thus func-
tionally homologous to mammalian CSF1R.
Csf1r Regulates Microglia Density and Distribution
Independent of Brain Pathology
Previous studies indicate that the density of tissue macro-
phages, including microglia, is affected by reduced CSF1R
signaling (Naito et al., 1991; Sasaki et al., 2000; Umeda et al.,
1996; Wegiel et al., 1998). To validate this in zebrafish, we
used neutral red labeling and immunohistochemistry to assess
microglia numbers in a series of csf1r mutant zebrafish larvae
consisting of csf1ra+/, csf1ra/, csf1rb/, csf1ra/;b+/,
and csf1rDM animals. At the larval stage, a gradual reduction in
the number of csf1r alleles resulted in a corresponding decrease
in microglia numbers (Figures 1C–1E). The greater reduction in
microglia numbers in csf1ra/ mutants than in csf1rb/ mu-
tants suggests that csf1ra is more important during early devel-
opment. In adult zebrafish, however, microglia numbers in
csf1rb/ mutants were strongly reduced, whereas, in csf1ra/
mutants, they were more comparable with those in the wild-type
(Figure 2C), suggesting differential requirements of csf1ra and
csf1rb in microglia at different developmental stages. Surpris-
ingly, in 5-month-old adult csf1ra/;b+/ mutants, we observed
that, although microglia were absent in the dorsolateral side of
the optic tectum, they appeared to accumulate in the underlying
deep brain regions (Figures 2A and 2B).
To investigate whether any pathological hallmarks of ALSP are
also present in csf1r mutant zebrafish, we assessed tissue and
white matter integrity in adult csf1ra/, csf1ra/;b+/, and
csf1rDM mutants. H&E labeling did not reveal signs of brain pa-
thology (data not shown), nor did immunolabeling for Claudin K
(Cldnk)—which labels myelin tracts throughout the zebrafish
brain—reveal major loss of myelin, even in csf1rDM mutants
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Figure 1. Microglia Numbers during Development
Are csf1r Dosage-Dependent
(A) Counts per million (CPM) expression values of csf1ra
and csf1rb from our previous RNA sequencing study in
adult zebrafish microglia (Oosterhof et al., 2017).
(B) Schematic representation of the csf1rb mutation
introduced with TALEN-mediated genome editing.
(C and D) 5 days post fertilization (dpf), WT, csf1ra/,
csf1rb/, csf1ra/;b+/, and csf1rDM larvae were treated
with neutral red for 2.5 hr. Images were acquired with a
stereomicroscope, and microglia numbers were deter-
mined by counting the number of neutral red dots. n is at
least 15 zebrafish/genotype for (C) and at least 7 for (D).
(E) 4 dpf, WT, csf1ra/ , csf1ra/;b+/ and csf1rDM were
labeled with an antibody against L-plastin (Spangenberg
et al., 2016), and L-plastin-positive cells were quantified in
the optic tecti. n is at least 6 zebrafish/genotype.
LBD, ligand-bindingdomain; TMD, transmembranedomain;
TKD, tyrosine kinase domain. Error bars represent SD.
**p < 0.01, ***p < 0.001 (one-way ANOVA, Bonferroni
multiple testing correction). Scale bar, 40 mm.
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(Figure S2A; M€unzel et al., 2012). To determine whether
csf1r mutants display more subtle myelin abnormalities, such
as degeneration, hypomyelination, or hypermyelination, we
analyzed their white matter by electron microscopy (EM). We
observed highly myelinated regions in the midbrain containing
multilayered myelin sheets that resembled those in mammals
but no apparent abnormalities in the multilayered myelin sheets
in csf1r mutants (Figures S2B and S2C). Immunolabeling for
Sox10 also indicated normal numbers of oligodendrocyte line-
age cells in csf1r mutants (Figure S2D). Together, this indicates
that csf1r deficiency in zebrafish does not result in overt myelin
degeneration at this adult stage.
To establish whether loss of csf1r causes more subtle patho-
logical changes, we performed RNA sequencing on brains of
adult csf1rmutant zebrafish that were8months old (Figure 3A).
Multidimensional scaling of gene expression data showed clus-
tering of the samples based on the csf1r mutation status (wild-
type [WT], csf1ra/, csf1ra/;b+/, and csf1rDM), indicating
csf1r-dependent changes in gene expression (Figure 3B). Differ-
ential gene expression analysis betweenWT and csf1rDMmutant
brains revealed 154 differentially expressed genes, 85 of which
(e.g., spi1b, irf8, csf1ra, and csf1rb) we had previously identified
as part of the zebrafish microglial transcriptome (Figures 3C–3E;
Table S2; Oosterhof et al., 2017). Hierarchical clustering of the
samples on the basis of 154 differentially expressed genes
revealed that csf1ra/;b+/ mutants clustered with csf1rDM
mutants, whereas csf1ra/ mutants clustered with the WT
(Figure 3D). This suggests that loss of csf1r leads mainly to
reduced expression of microglia-specific genes, which indi-
cates that loss of csf1r in zebrafish predominantly affects
microglia. The downregulated genes that were not specifically
expressed in microglia included the cysteine-glutamine
exchanger slc7a11 and growth hormone 1 as well as many
poorly annotated genes (Table S2). This indicates that csf1r
deficiency and, thus, loss of microglia causes very few
molecular changes and no obvious myelin-related pathology in
8-month-old adult zebrafish.
Csf1r-Deficient Microglia Increase the Expression of
Genes Involved in Chemotaxis and Migration
To assess in more detail how csf1r deficiency affects micro-
glia independently of brain pathology, we performed RNA
sequencing on microglia that were sorted by fluorescence-acti-
vated cell sorting (FACS) fromWT, csf1ra/, and csf1ra/;b+/
mutant brains that were dissected from 9-month-old zebrafish
(Figure 4A). Multidimensional scaling revealed clustering of the
samples on the basis of csf1r mutation status, indicating csf1r-
dependent changes in microglial gene expression (Figure 3B).
Based on our microglia density measurements and the impor-Figure 2. Altered Microglia Distribution and Numbers in the Adult csf1
(A) Representative images of microglia in WT, csf1ra/, csf1ra/;b+/, and csf1r
with antibody against L-plastin (n = 3 zebrafish/group).
(B) Microglia in (a) the ventral part of the optic tectum and (b) the dorsolateral pa
(C) Representative images of microglia in WT, csf1ra/, and csf1rb/ brain s
zebrafish/group).
Microglia were quantified in 3 areas (2.5 3 106 mm3) per brain region per animal.
Bonferroni multiple testing correction). Scale bars in (A) and (B), top, indicate 20tance of csf1rb for adult microglia, we reasoned that csf1ra/;
b+/mutant microglia could mimic the CSF1R haploinsufficiency
that occurs in ALSP patient microglia and compared the micro-
glia gene expression of these mutants with that of controls. We
identified 1,466 genes that were differentially expressed be-
tween csf1ra/;b+/mutant andWT microglia (Figure 4C; Table
S3). Interestingly, the normalized expression values of 750 of the
1,466 differentially expressed genes in csf1ra/ mutant micro-
glia lay in between those of csf1ra/;b+/ andWTmicroglia (Fig-
ures 4C and 4D; Table S3). Because more than half of the genes
differentially expressed between WT and csf1ra/;b+/ show
csf1r-dependent changes in expression, this indicates that these
genes are regulated by Csf1r signaling, and their altered expres-
sion could be a primary consequence of csf1r deficiency. Gene
ontology analysis of genes that showed csf1r-dependent
changes in expression revealed that downregulated genes
were associated with brain and nervous system development
and with regulation of neuronal differentiation (Figure 4E). Upre-
gulated genes were mainly associated with immune response,
immune system process, and leukocyte chemotaxis (Figure 4F).
The differentially expressed genes in the gene ontology classes
associated with the upregulated genes were mainly chemokines
and chemokine receptors (e.g., cxcl12a, ccl25b, ccl19a.1, and
cxcr4b) (Figure 4G). In fact, the expression of most chemokines
and chemokine receptors in zebrafish microglia was higher in
csf1ra/;b+/ mutants than in the WT (Figure 4G), which may
explain the aberrant microglia distribution in csf1ra/;b+/
mutants.
To test whether the expressional changes observed in
csf1ra/;b+/microglia and the brain indicated a general micro-
glia differentiation defect, we investigated whether adult csf1r
mutants showed a loss of microglia-specific gene expression
or a gain in gene expression associated with immature microglia
or macrophages (Figures 4 and 5). Only 8 of the 300 most micro-
glia-specific genes in zebrafish (many of which are also included
in the mouse and human homeostatic microglia signature; e.g.,
slco2b1, pdgfba, and scn4bb) were significantly downregulated
in csf1ra/;b+/ microglia, suggesting that there is no loss of a
homeostatic microglia signature (Figures 5A, 5D, and 5E; Butov-
sky et al., 2014; Gosselin et al., 2017; Oosterhof et al., 2017;
Zhang et al., 2014).
Next we analyzed the expression of 378 zebrafish orthologs
for genes that are strongly downregulated during microglia dif-
ferentiation in the mouse brain to assess whether csf1r mutant
microglia fail to downregulate genes specific to immature micro-
glia (Matcovitch-Natan et al., 2016). Expression of only 10 of
these 378 genes was increased in csf1ra/;b+/ mutant micro-
glia compared with the expression in WT microglia (Figures 5B
and 5F). We also found no evidence for increased expressionr Mutant Brain
DM brain sections from zebrafish aged 5 months post fertilization (mpf), stained
rt of the optic tectum of WT, csf1ra/, csf1ra/;b+/, and csf1rDM.
ections from 15 mpf zebrafish stained with antibody against L-plastin (n = 3
Error bars represent SD. *p < 0.05, **p < 0.01, ***p < 0.001 (one-way ANOVA,
0 mm; in (A) and (B), bottom, and in (C), scale bars indicate 50 mm.
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Figure 3. RNA Sequencing Reveals No Signs of Brain Pathology in csf1r Mutant Zebrafish
(A) Schematic representation of the whole-brain RNA sequencing experiment. RNA was isolated from whole brains of WT, csf1ra/, csf1ra/;b+/, and csf1rDM
fish (3 brains per sample, 2–3 samples per genotype).
(B) Multidimensional scaling plot.
(C) Volcano plot with genes differentially expressed between csf1rDM and WT fish. Yellow dots represent genes that are part of the zebrafish microglia tran-
scriptome (Oosterhof et al., 2017). Black dots represent the other differentially expressed genes. Gray dots represent all detected genes.
(D) Heatmap with genes differentially expressed between csf1rDM and WT fish genes.
(E) Expression values of differentially expressed microglia-specific genes.
Genes were differentially expressed with false discovery rate (FDR) < 0.05 and log fold change (LogFC) > j1j.of genes that discern microglia and macrophages (Figure 5C;
Bennett et al., 2016). Additionally, csf1ra/;b+/ microglia
were still highly ramified and showed no signs of activation (Fig-
ure 5G). This suggests that the csf1r-dependent changes in
microglial gene expression are largely independent of differenti-
ation status. Together, these data imply that the changes in the
expression of genes involved in chemotaxis and cell migration
in csf1r mutants are a specific consequence of csf1r deficiency
and not of a global differentiation defect.
The Damage-Induced Proliferative Response of csf1r
Mutant Microglia Is Delayed
Microglia respond quickly to damage by migration and prolifera-
tion, and CSF1R has been linked to this proliferative response of
microglia (Go´mez-Nicola et al., 2013). Therefore, to assess
whether proliferation defects could be linked to aberrant micro-
glia localization and, possibly, to microglia migration, we used
our previously established neuronal ablation model. In this1208 Cell Reports 24, 1203–1217, July 31, 2018model, metronidazole (MTZ) treatment in zebrafish with brain-
specific transgenic expression of nitroreductase (NTR) results
in neuronal cell death (van Ham et al., 2012, 2014). We have
shown previously that increasing the local demand for microglia
by inducing neuronal cell death causes a strong local prolifera-
tive response bymicroglia (Oosterhof et al., 2017). To investigate
whether microglia proliferation depends on csf1r dosage, we
used proliferating cell nuclear antigen (Pcna) as a cell prolifera-
tion marker to assess microglia proliferation upon induction of
neuronal ablation. One day after treatment, control NTR trans-
genic larvae showed that the microglia numbers had increased
from 25 to 32 locally, with a corresponding increase in the frac-
tion of Pcna+ microglia (Figure 6A). In contrast, csf1r mutant mi-
croglia, upon MTZ treatment, showed a much larger increase in
microglia numbers, respectively, from 5 to 24 and from 2 to12,
but had not yet increased significantly in the fraction of Pcna+mi-
croglia (Figure 6A). Therefore, the increased microglia numbers
in treated csf1r mutants cannot be explained by the fraction of
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Figure 4. RNA Sequencing Reveals Increased Expression of Genes Associated with Chemotaxis in csf1ra/;b+/ Mutant Microglia
(A) Schematic representation of the RNA sequencing experiment. Microglia were sorted by FACS fromdissected brains fromWT (3 brains per sample, 2 samples),
csf1ra/ (3 brains per sample, 2 samples), and csf1ra/;b+/ (4–5 brains per sample, 2 samples) zebrafish.
(B) Multidimensional scaling plot.
(C) Heatmap of differentially expressed genes between csf1ra/;b+/ and WT microglia.
(D) Volcano plot of differentially expressed genes (csf1ra/;b+/ versus WT) whose expression values in csf1ra/ mutants lay between those of WT and
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(E and F) Gene ontology analysis was performed on genes that showed a csf1r-dependent decrease in expression (E) and increase in expression (F).
(G) Heatmap with expression Z scores for all chemokines and chemokine receptors that are expressed in zebrafish microglia.
Genes were differentially expressed with FDR < 0.01 and LogFC > j2j. Adult zebrafish used were between 9–12 months old.dividing microglia relative to the control. Based on the much
stronger increase in L-plastin+ cells in either of the mutants,
however, onewould expect amuch higher fraction of Pcna+ cells
in MTZ-treated cells versus controls if the increase is due to pro-
liferation alone. Intriguingly, 2 days after treatment, the fractions
of Pcna+ microglia were increased to similar levels in control
and in csf1r mutants (Figure 6B). This showed that, although
csf1ra/ and csf1ra/;b+/ mutant microglia were able to
mount a proliferative response, the proliferative response was
delayed. Nevertheless, because numbers still increased, itseems that potential initial proliferation deficiencies were
compensated through microglia recruitment. Therefore, the
aberrant distribution of microglia upon csf1r deficiency (Figures
2A and 2B) may be a compensatory mechanism intended to
meet the brain’s local demand for microglia.
Severe Microglia Depletion in Gray and White Matter of
Postmortem ALSP Patient Brains
It has been reported that degenerated white matter in the
brains of ALSP patients contains many CD68+ myeloid cellsCell Reports 24, 1203–1217, July 31, 2018 1209
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and reduced numbers of IBA1-positive microglia (Konno et al.,
2014; Oyanagi et al., 2017; Tada et al., 2016). We wanted to
investigate whether altered microglia density and distribution,
as we identified in zebrafish, would recur in non-degenerated
brain tissue of ALSP patients. By immunohistochemistry, we
therefore analyzed microglia morphology, distribution, and den-
sity in gray matter, normal-appearing white matter (NAWM; oc-
cipital lobe), and degenerated white matter (middle frontal gyrus
and cingulate gyrus) of two ALSP patients and age-matched
controls (Figures 7 and S4A). As in previous studies, we
observed numerous HLA-DR+ cells and large, rounded CD68+
cells in degenerated white matter, whereas, apart from a few
IBA1/CD68-double-positive cells, IBA1+ cells were almost
completely absent (Figures 7A, S3A–S3C, and S4B). Because
we also observed a few CD68+ cells with a low level of IBA1
staining, this suggests that highly CD68+ cells lose IBA1 expres-
sion (Figure S3D).
Most IBA1+ microglia still present in the degenerated white
matter appeared in clusters of 10–100 cells (Figure 7B). Inter-
estingly, with the exception of sparse microglia clusters, micro-
glia in NAWM and gray matter were also severely depleted (Fig-
ures 7B, 7C, S3B, and S3C). Many of these IBA1+ microglia
clusters were located at the border between the gray and the
white matter (Figure 7B). Although the few IBA1+ cells present
in the white matter looked like foam cells, microglia in the gray
matter and NAWM either looked activated or had a normal rami-
fied morphology (Figure 7B). In all brain areas examined, we also
observed areas of gray matter in which IBA1+ microglia had a
normal distribution and a ramified morphology. However, the
density of thesemicroglia was50% lower in ALSP patient brain
sections than in controls (Figure 7D). This is reminiscent of the
findings in our zebrafish experiments, where we also observed
regional differences in microglia density in unaffected brain tis-
sue (Figures 2 and 7B and 7D). The loss of IBA1+ microglia
and the aberrant microglia distribution and altered morphology
in microglia clusters—not only in the gray matter but also in
NAWM—indicate that microglial changes could precede white
matter degeneration.
Discussion
Although mutations in genes that are particularly important for
microglia can cause severe brain disorders, it is still unclear
whether pathogenesis involves a gain or loss of specific micro-
glia activities. Here we used zebrafish to investigate the effect
of a gradual reduction in functional csf1r alleles on microglia
numbers and microglia differentiation status and their response
to tissue damage. We found that Csf1r haploinsufficiency was
correlated with a lower density of microglia in the dorsal part of
the optic tectum. Additionally, we observed altered microglia
distribution and local microglia depletion in the ventral and
dorsolateral part of the optic tectum, respectively. Loss of three
csf1r alleles did not severely impede the proliferative capacity oftreated with MTZ at 5 dpf for 16 hr and fixed for immunohistochemistry (wh
dividing (Pcna+) microglia (L-plastin+), and the entire forebrain (dotted lines)
n = 10 zebrafish larvae (A) and at least n = 4 (B). Error bars indicate SD. *p
multiple testing correction).
1212 Cell Reports 24, 1203–1217, July 31, 2018microglia to dying neurons, nor did it affect the homeostatic mi-
croglia signature. Instead, in response to increased phagocytic
demand, csf1rmutant microglia initially increased their numbers
locally through recruitment rather than proliferation. Accordingly,
the expression of migration and chemotaxis genes in csf1r mu-
tants was also increased. We also showed that, in the absence
of extensive white matter degeneration in the occipital lobe of
the cortex, CSF1R haploinsufficiency results in widespread
depletion and aberrant distribution of IBA1+ microglia in hu-
mans. These findings support the presence of a disease mech-
anism in which CSF1R haploinsufficiency reduces microglia
density, causes microglial relocation, and results in depletion
of functional microglia.
Although the focus of this study is brainmicroglia, CSF1R hap-
loinsufficiency could potentially affect other macrophages, such
as those in the gut, or even neurons, because a low level of Csf1r
expressionwas reported in a few scattered neurons in themouse
hippocampus (Luo et al., 2013). Because the composition of the
gutmicrobiome or perturbed barrier function of the gut hasmajor
effects on microglia and on the CNS (Erny et al., 2015; Sampson
et al., 2016) it is possible that, in ALSP patients, defects in other
macrophage populations, such as those in the intestine, play a
role in pathogenesis. Nevertheless, gastrointestinal symptoms
related to perturbed gut barrier function were not reported in
ALSP patients (Konno et al., 2017). Additionally, our zebrafish
data do not imply an increased inflammatory response or
response to microbial infection. Given that a potentially protec-
tive role of Csf1r has been described in neurons, it is possible
that these protective effects are reduced due to CSF1R defi-
ciency and could be a contributing factor in disease. Because
neuronal loss is not obvious in ALSP patients, however, and
severe phenotypes of Csf1r/ mice are largely rescued by
hematopoietic cells, we speculate that this is unlikely to play a
major part (Bennett et al., 2018).
The CSF1R coding sequence and function are well conserved
across species. CSF1R-deficient zebrafish, rodents, and, most
likely, humans lack microglia, are osteopetrotic, and occasion-
ally show cerebral hemorrhages (data not shown; Dai et al.,
2002; Erblich et al., 2011; Ginhoux et al., 2010; Monies et al.,
2017). Our data indicate that csf1r haploinsufficiency leads to
local loss of microglia, possibly throughmaldistribution of micro-
glia. This is similar to the aberrant distribution of microglia and
widespread loss of microglia we observed in the NAWM and
gray matter of postmortem ALSP patient brains. Interestingly,
based on neuropathological analysis of different ALSP stages,
in the early stages, microglia numbers were predicted to be
higher than in controls, and microglia appear to be activated in
specific brain regions (Oyanagi et al., 2017). This is reminiscent
of the increased microglia density we observed in deep brain
regions of csf1ra/;b+/ haploinsufficient zebrafish (Oyanagi
et al., 2017). Similarly, microglia numbers are also higher in
some brain regions in heterozygous Csf1r mutant mice than inole-mount) at 6 dpf (A) and 7 dpf (B). Immunostaining was performed for
was imaged and quantified. Scale bars, 40 mm. Group sizes were at least
< 0.05, **p < 0.01, ***p < 0.001, *p < 0.0001 (one-way ANOVA, Bonferroni
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control animals, but it is unclear whether microglia density is
reduced in other areas or at later stages in the mouse (Chitu
et al., 2015). Between them, these observations indicate that
CSF1R haploinsufficiency causes aberrant microglia distribu-
tion, where some regions become devoid of microglia.
Although microglia are efficient phagocytes that clear dead
cells, dysfunctional synapses, and myelin (Ling, 1979; Safaiyan
et al., 2016; Sierra et al., 2010), the accumulation ofmyelin debris
in microglia can compromise their phagocytic capacity and can
also lead to microglial senescence (Boven et al., 2006; Neumann
et al., 2009; Safaiyan et al., 2016). Based on the size and
morphology of large numbers of CD68+ cells in degenerated
white matter, the accumulation of debris could have preceded
their presence. We cannot exclude that CD68+ cells include in-
filtratedmacrophages because other macrophage andmicroglia
markers, including IBA1 and P2RY12, appear to be lost or very
low in these cells (Tada et al., 2016). Regardless, accumulation
of myelin debris, as occurs during normal aging, may contribute
to the progressive loss of functional IBA1+ microglia over the
course of the disease. In fact, it was shown in a tuberculosis
infection model that, because of reduced csf1r signaling, the
loss of macrophages was driven by a failure to meet phagocytic
demand (Paga´n et al., 2015). Consistent with this idea, the
morphology of microglia among clusters in ALSP patients
ranged from ramified to completely round and foamy in appear-
ance, most likely because of the accumulation of phagocytized
myelin debris in microglia (Boven et al., 2006). Simultaneously,
it is possible that one functional CSF1R copy is not sufficient
to sustain both normal microglia survival and proliferation
because microglia turn over in humans in adulthood (Askew
et al., 2017; Re´u et al., 2017). Together, this indicates that
CSF1R-dependent loss of microglia in ALSP patients may be
progressive.
The absence of overt neuropathology or myelin pathology in
csf1r mutant zebrafish may be related to their relatively young
age, the fact that the CNS of the zebrafish is smaller and less
complex than that of humans, or the time needed for the pathol-
ogy to develop in humans. The pathological hallmarks of ALSP
are observed mainly in the neocortex, which is unique to mam-
mals and has expanded immensely during evolution, particularly
in primates and humans (Florio and Huttner, 2014; Hofman,
2014). Because the neocortex is rich in white matter, it may be
more susceptible to pathology than the zebrafish brain, in which
there is relatively little white matter (Merrifield et al., 2017).
Consistent with this, mutations that result in a relatively mild pa-
thology in mice can lead to severe leukodystrophy in humans
(Choquet et al., 2017). Additionally, it takes about 30–40 yearsFigure 7. ALSP Patient Brains Show Widespread Microglia Depletion.
Shown are representative images of IBA1 and CD68 staining of microglia in whi
age-matched control donors.
(A) IBA1 and CD68 double-labeling in the white matter of the cingulate gyrus of A
(B) Clusters of IBA1+ microglia are apparent at the borders between the gray ma
(C) Severe depletion of IBA1+ microglia in the gray and white matter of the occip
(D) The ramified morphology of microglia in gray matter areas of ALSP patients w
areas of the cingulate cortex, frontal cortex, and occipital cortex showed a homog
per brain region per patient). Error bars indicate SD.
Scale bars, 50 mm (A), 500 mm (B, low magnification), 30 mm (B, high magnificatio
1214 Cell Reports 24, 1203–1217, July 31, 2018before ALSP becomes symptomatic, whereas mice and zebra-
fish live only a few years (Konno et al., 2017). Even though the
csf1rmutant zebrafish brain is relatively unaffected, the direct ef-
fects of csf1rmutations onmicroglia as described herewere very
similar to those in humans.
Although it is still unknown how long-term depletion of micro-
glia in adulthood would affect brain homeostasis and how it
might cause pathology, white matter degeneration is a hallmark
of several other brain disorders classified as microgliopathies.
For example, mutations in the microglia genes TREM2 and
TYROBP cause Nasu-Hakola disease (NHD), which is also char-
acterized by white matter pathology. Even though the precise
pathogenicmechanisms remain elusive, these disorders support
the idea that microglia are critical to themaintenance of myelin in
adulthood. In fact, it was recently shown in the adult brain that
lowermicroglia numbers lead to a reduction in the numbers of ol-
igodendrocytes or OPCs in many brain regions (Hagemeyer
et al., 2017). We anticipate that a progressive depletion of
microglia occurs in ALSP that could lead to a lower number of
myelinating cells in adulthood and could contribute to ALSP
pathogenesis.
Like tissue macrophages, microglia influence the develop-
ment and repair of organs by secreting trophic factors, including
insulin-like growth factor 1 (IGF1), and bymediating signaling be-
tween cells (Eom and Parichy, 2017; Wlodarczyk et al., 2017;
Wynn et al., 2013). Local depletion of microglia could lead to a
failure to provide such trophic factors, which could contribute
to ALSP pathogenesis; for example, by affecting the capacity
to form new oligodendrocytes.
In conclusion, the greatest effect of CSF1R haploinsufficiency
seems to be a general reduction in microglia density in addition
to large areas completely devoid ofmicroglia. The partial or com-
plete lack of microglia occurs in normal-appearing gray matter
and NAWM, which suggests that loss of microglia may eventu-
ally result in ALSP pathology. Our gene expression data in an
allelic series of csf1r-deficient microglia and brains therefore
provide an opportunity to further delineate not only the function
of csf1r in microglia but also the consequences for the brain.
Elucidating these is crucial for a more comprehensive under-
standing of the physiological functions of microglia and micro-
glia-dependent disease mechanisms. Several studies have
shown that pharmacological inhibition of CSF1R causes micro-
glia depletion and that, in mousemodels, it ameliorates neurode-
generative disease-like symptoms by depleting microglia or
diminishing their proliferation and activation (Elmore et al.,
2014; Olmos-Alonso et al., 2016; Spangenberg et al., 2016).
Because microglia depletion may underlie and contribute tote and gray matter of postmortem brain tissue of two ALSP patients and two
LSP patient and control tissue.
tter and the white matter.
ital cortex.
as similar to that in controls. Quantification of microglia numbers in gray matter
eneous distribution of ramified microglia (5 gray matter areas, 1.5 mm2 in size,
n), 100 mm (C), 50 mm (D). WM, white matter; GM, gray matter.
the development and progression of ALSP, this raises the
question of whether long-term inhibition of CSF1R in neurode-
generative diseases like Alzheimer’s disease is a viable treat-
ment option (Olmos-Alonso et al., 2016; Spangenberg et al.,
2016). This warrants further studies to determine how the brain
is affected by loss of microglia interactions and microglia-
derived factors and to devise ways of promoting the supply of
functional microglia.
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Zebrafish control and csf1r mutant brain
RNA-sequencing data
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release/bioc/html/edgeR.html
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animal models
All zebrafishweremaintained under standard conditions. Adult animals were kept in groups on a 14 hr light and 10 hr dark cycle. They
were fed brine shrimp twice a day. Embryos were kept at 28C in 10 mM HEPES-buffered E3 embryo medium. In larvae analyzed
between 3-5 dpf sex-determination has not yet occurred. For microglia RNA-sequencing experiments groups of 3 animals were
used, containing at least 1 male and 1 female. For whole brain RNA-sequencing groups of 3 animals, 1 male and 2 females, were
used. The following existing transgenic or mutant zebrafish lines were used: Wild-type AB, Tg(mpeg1:EGFP) fish expressing
GFP under the control of the mpeg1 promotor (Ellett et al., 2011), Tg(shhb:KalTA4,UAS-E1b:mCherry, UAS-E1b:NTR-mCherry,Cell Reports 24, 1203–1217.e1–e6, July 31, 2018 e2
mpeg1:EGFP) with neuronal specific nsfB expression encoding nitroreductase (NTR)(Davison et al., 2007; van Ham et al., 2014),
csf1raj4e1/j4e1 with a V614M substitution in the first kinase domain (Parichy et al., 2000). Csf1ra mutants were also crossed in with
the transgenic lines specified above. The csf1rb deletion mutant was created by TALEN-mediated genome editing (Cermak et al.,
2011). The TALEN arms targeted exon 3 (Figure S1) of the csf1rb gene, resulting in a 4 bp deletion and premature stop codon. These
zebrafish deficient in csf1rb, csf1rbre01/re01, lose an MspI restriction site which was used for genotyping. Animal experiments were
approved by the Animal Experimentation Committee at Erasmus MC, Rotterdam.
Human post mortem brain tissue
Human brain tissue sampleswere obtained from theNetherlands Brain Bank (https://www.brainbank.nl/). All patients and controls, or
their next of kin, had given informed consent for autopsy and the use of brain tissue for research purposes. Relevant clinical infor-
mation was retrieved from the medical records and is summarized in Table S1. We obtained paraffin-embedded post mortem tissue
blocks of cingulate gyrus, frontal cortex, and occipital lobe from 2 ALSP patients and 2 age-matched controls without neurological
disease.
METHOD DETAILS
Vital dye labeling
Neutral red labeling was performed as described previously (Herbomel et al., 2001). For all experiments in larvae, embryos were kept
in E3 medium containing 0.003% 1-phenyl 2-thiourea (PTU) (Sigma-Aldrich) from 22 hpf onward. To assess microglia numbers, 5 or
6 dpf larvae were treated with 2.5 mg/ml neutral red in E3+PTU medium at 28C for two hr. After two hr, larvae were incubated in
E3+PTU for at least 30 min before imaging. For imaging, larvae were anesthetized with 0.016% MS-222 (Sigma-Aldrich) and
embedded in 1.8% low melting point (LMP) agarose (VWR BDH Prolabo) with the dorsal side facing upward. Neutral red images
were acquired by using a Leica M165FC stereo microscope.
Conditional neuronal cell death
For neuronal ablation, neuro-NTR transgenic zebrafishwere used as described previously (Davison et al., 2007; van Hamet al., 2014).
Larvae were treated with 2 mM metronidazole (MTZ) dissolved in DMSO at 28C for 16 hr. MTZ was washed away with E3+PTU
medium. Larvaewere euthanized and fixed at different times after the start of treatment, at 1 day post treatment (20 h) and 2 days post
treatment (48 h).
Immunofluorescence staining
Whole mount larvae This was usually done as described previously (Inoue and Wittbrodt, 2011). Larvae were fixed in 4% PFA at 4C
overnight, dehydrated to 100%MeOH, and kept at 20C for at least two days. They were then rehydrated to PBSTw (PBS + 0.1%
Tween). Antigens were retrieved by incubating the larvae in 150 mM Tris-HCl pH = 9.0 for 5 min, followed by incubation at 70C for
15 min. Afterward, larvae were washed with PBSTw (2x 10 min) and dH2O (2x 5 min) and incubated in acetone at 20C for 20 min.
This was followed by several washing steps in PBSTw (6x 5 min); dH2O (2x 5 min); and PBSTw (2x 5 min). The larvae were then incu-
bated in blocking buffer (10% goat serum, 1% Triton X-100, 1%BSA in PBSTw) at 4C for 3h. Primary-antibody labeling (1st antibody
in 1% goat serum, 0.8% Triton X-100, 1%BSA in PBSTw) was done at 4C for three days. Larvae were washed in PBS-TS (10% goat
serum, 1% Triton X-100 in PBS) (3x 1h); PBST (1% Triton X-100 in PBS) (2x 10 min); and PBS-TS (2x 1 h). The larvae were then incu-
bated with the secondary antibody and Hoechst at 4C for 2.5 days. Before imaging, the larvae were washed with PBS-TS (3x 1 h);
and PBSTw (2x 1 h). Primary antibodies: PCNA (1:250, Dako); and L-plastin (1:500; gift from Yi Feng, University of Edinburgh). Sec-
ondary antibodies: DyLight alexa 488 (1:500); and DyLight alexa 647 (1:500). Hoechst was used for nuclear staining. Images were
taken with a Leica SP5 confocal microscope using a 20x water dipping lens (NA = 1.0). Total microglia numbers were quantified
for the entire brain. The microglia response to neuronal death was quantified in the larval forebrain.
Adult brain sections
Immunostaining on adult brain slices was performed largely as described previously (Oosterhof et al., 2017). Fish were euthanized in
ice water, after which the skull (containing the brain) was fixed in 4% PFA at 4C overnight. Subsequently, the brains were carefully
removed and dehydrated with a 25%, 50%, 75%, 100%MeOH series and kept at 20C for at least 12 hr. After rehydration, brains
were embedded in 4% w/v low melting point agarose in PBS and cut into 80 mm horizontal sections using a Microm HM 650V vibra-
tome (ThermoFisher Scientific). Immunostainings on free-floating sections were performed as described. The sections were incu-
bated in blocking buffer (10% goat serum, 0.5% Triton X-100 in PBS) at room temperature for 75 min, followed by incubation
with the primary antibody in blocking buffer at 4C overnight. The sections were thoroughly washed with PBST (0.5% Triton
X-100) before incubation with the secondary antibody and Hoechst at 4C overnight. The brain slices were then washed with
PBST (53 30-60 min) and mounted onmicroscope slides using vectashield mounting medium H1000 (Vector Laboratories). Primary
antibodies: L-plastin (1:1000; gift from Yi Feng, University of Edinburgh); ClaudinK (1:1000; gift from Thomas and Catherina Becker,
Edinburgh); and Sox10 (1:500, Genetex). Secondary antibodies used were DyLight alexa 488 and DyLight alexa 647 (1:500,
ThermoFisher Scientific, Waltham, US), and alexa 594 (1:250, Invitrogen, Waltham, US). Imaging was done with a Zeiss LSM700
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Immunohistochemistry zebrafish paraffin sections
4.5 month old zebrafish were euthanized in ice water and fixated in 4%PFA at 4C over the weekend. Thereafter fish were washed in
PBS before transferring them to 20%EDTA at room temperature for weeks for the bone to decalcify. Fish were embedded in paraffin
and 10mm sections were cut and dried overnight at 37C. Sections were deparaffinized and rehydrated to distilled water. Antigen
retrieval was performed by heating in 0.01M sodium citrate pH = 6 for 13 min. After cooling slices were rinsed with PBS before block-
ing endogenous peroxidase activity by 30min incubation in 0.6%H2O2, 1.5% sodium azide in PBS at room temperature. Slides were
rinsed in PBS+ (0.5% protifar, 0.15% glycine) before L-plastin antibody incubation (1:1000) overnight at 4C in PBS+. Slides were
rinsed with PBS+ before incubation with conjugated secondary antibody (anti-rabbit-HRP 1:100) for 60 min at room temperature.
After washing in PBS+ and PBS slides were incubated in DAB-substrate (DAKO liquid DAB substrate-chromogen system). After
washing with distilled water a counterstaining with hematoxylin was performed for 5 min. After washing in distilled water slices
were dehydrated and mounted with Entellan (Merck).
Paraffin sections human brain
Tissue sections were characterized for the presence of microglia by staining for IBA1, HLA-DR and CD68 as previously described
(Hovens et al., 2014). Paraffin sections seven mm in thickness were collected on Superfrost Plus glass slides (VWR international,
Leuven, Belgium) and dried at 37C overnight. Tissue sections were deparaffinized and rehydrated to distilled water. Endogenous
peroxidase was quenched in 0.3% H2O2 (Merck, Darmstadt, Germany) in phosphate-buffered saline (PBS), and antigen was
retrieved by heating the slides in citrate buffer (10 mM; pH 6.0). The sections were then incubated with normal horse serum blocking
buffer (TBS supplemented with 2% horse serum, 1% bovine serum albumin (Sigma-Aldrich, St. Louis, USA); 0.1% Triton X-100 and
0.05% Tween (Merck)) for 30 min at RT. Thereafter, sections were incubated with rabbit anti-human IBA1 antibodies (1:1000 TBS-
BSA 1%;WAKOChemicals, Richmond, USA) overnight at 4C. After rinsing, the sections were incubated with biotinylated goat anti-
rabbit antibodies (1:400 in TBS-BSA 1%; Vector Laboratories, Burlingame, USA) for 1 h at RT; this was followed by incubation with
the avidin-biotin complex (1:800 in TBS; Vector Laboratories) for 450 at RT, The sections were then developed with 3,30-diaminoben-
zidine (DAB; 0.05 mg/ml, Sigma-Aldrich). After washing in distilled water, slides were dehydrated and embedded in Entallan (Merck).
In between all steps, sections were extensively rinsed in TBS.Whole slides were digitalized using a NanoZoomer digital slide scanner
(Hamamatsu) and the slides were analyzed using Hamamatsu software NDPview2. The numbers of IBA1+ microglia were quantified
in 5 areas of 1.5 mm2 per brain region per patient.
For the CD68/IBA1 immunofluorescent double-staining, tissue sections were deparaffinized and rehydrated to distilled water. An-
tigen retrieval was performed by heating the slides in citrate buffer (10mM; pH 6.0). Sections were then rinsed in blocking buffer (PBS,
0.5% protifar (Nutricia), 0.15% glycine (Sigma-Aldrich, St. Louis, USA), 0.4% Triton X-100) for 2 times 2 min at RT. Thereafter, sec-
tions were incubated with blocking buffer containing rabbit anti-human IBA1 (1:500, WAKO Chemicals, Richmond, USA) and mouse
anti-human CD68 (1:50, clone KP-1) antibodies overnight at 4C. After rinsing with blocking buffer, sections were incubated with sec-
ondary anti-rabbit Alexa 488 (1:200, ThermoFisher Scientific, Waltham, US) and anti-mouse Cy3 antibodies (1:200) for 1h at RT. Au-
tofluorescence was blocked by incubating slides in Sudan Black solution for 5 min at RT. After washing the slides were embedded in
Mowiol containing DAPI.
Luxol fast blue staining
Paraffin sections seven mm in thickness were collected on glass slides (Superfrost Plus, VWR international, Leuven, Belgium) and
dried at 37C. Sections were deparaffinized and hydrated to 95% ethanol and incubated in Luxol fast blue solution (0.1% w/v luxol
fast blue, Sigma-Aldrich, in 95% ethanol) overnight at 55C. The sections were then quickly rinsed in 95% ethanol and incubated in
lithium carbonate solution (0.05% w/v, Sigma-Aldrich, in distilled H2O) for 30 s. Next, the samples were rinsed in 70% ethanol and
subsequently in ddH2O. The sections were dehydrated to 100% ethanol and mounted with Entallan (Merck). Whole slides were
digitalized using a NanoZoomer digital slide scanner (Hamamatsu), and the slides were analyzed using Hamamatsu software
NDPview2.
RNA sequencing
Whole brain
For whole brain transcriptomic analysis brains were dissected as described previously (Oosterhof et al., 2017) and snap frozen in
liquid nitrogen. Zebrafish between 6-12 mpf were used. Zebrafish were euthanized in ice water and heads were severed behind
the gills, and the lower jaw, gills, and eyes were removed. The brains were taken out of the skull and cut using scalpels. Brains
were homogenized followed by total RNA isolation using Trizol. Total RNA quality for triplicates of WT brain, csf1ra/ brain,
csf1ra/;b+/ brain and csf1rDM brain was assessed on an Agilent Technologies 2100 Bioanalyzer using a RNA nano assay. All sam-
ples had RIN value greater than 9.10. Triplicate RNA-seq libraries were prepared according to the Illumina TruSeq stranded mRNA
protocol (https://www.illumina.com). Briefly, 200 ng of total RNA was purified using poly-T oligo-attached magnetic beads to end up
with poly-A containing mRNA. The poly-A tailed mRNAwas fragmented and cDNAwas synthesized using SuperScript II and random
primers in the presence of Actinomycin D. cDNA fragments were end repaired, purified with AMPure XP beads, A-tailed using Klenow
exo-enzyme in the presence of dATP. Paired end adapters with dual index (Illumina) were ligated to the A-tailed cDNA fragments andCell Reports 24, 1203–1217.e1–e6, July 31, 2018 e4
purified using AMPure XP beads. The resulting adaptor-modified cDNA fragments were enriched by PCR using Phusion polymerase
as followed: 30 s at 98C, 15 cycles of (10 s at 98C, 30 s at 60C, 30 s at 72C), 5 min at 72C. PCR products were purified using
AMPure XP beads and eluted in 30 ml of resuspension buffer. Onemicroliter was loaded on an Agilent Technologies 2100 Bioanalyzer
using a DNA 1000 assay to determine the library concentration and for quality check.
Bridge amplification, sequencing by synthesis and data analysis
Cluster generation was performed according to the Illumina TruSeq SR Rapid Cluster kit v2 (cBot) Reagents Preparation Guide
(https://www.illumina.com/). Briefly, 12 RNA-seq libraries were pooled together to get a stock of 10 nM. One microliter of the
10 nM stockwas denaturatedwith NaOH, diluted to 6 pM and hybridized onto the flowcell. The hybridized products were sequentially
amplified, linearized, and end-blocked according to the Illumina Single Read Multiplex Sequencing user guide. After hybridization of
the sequencing primer, sequencing-by-synthesis was performed using the HiSeq 2500 with a single read 50-cycle protocol followed
by dual index sequencing. Reads were aligned against the GRCz10 genome using HiSat2 (version 2.0.4) (Kim et al., 2015). Counts
were generated for each gene from the Ensembl (version 85) transcriptome analysis of GRCz10, using htseq-count (version 0.6.0)
(Anders et al., 2015).
Microglia
Tg(mpeg1:EGFP) zebrafish were euthanized in ice water. The heads were severed behind the gills, and the lower jaw, gills, and eyes
were removed. The brains (4-5 per sample) were taken out of the skull and cut using scalpels. This was followed by dissociation in
0.25% trypsin and 0.1% EDTA in PBS for 2 hr at 4C, while resuspending regularly. Upon complete dissociation of the brain, trypsin
was inactivated by adding 1/6 volume of a stop solution (6 mMCaCl2 in PBS). The cells were collected in a 22%Percoll solution after
being run through a 70 mmcell strainer, and ice-cold PBSwas placed on top of the cell suspension and centrifuged at 1000 x g at 4C
for 45 min. The remaining cell pellet was resuspended in suspension solution (high-glucose DMEM without phenol red, 0.8 mM
CaCl2). The cell suspension was transferred to FACS tubes with 35 mm cell strainer caps and FAC-sorted using a FACSaria III cell
sorter (BD biosciences, New Jersey, USA). Dapi was added to exclude dead cells.
RNaseq library synthesis and bioinformatics analysis
Microglia were lysed and processed for RNA-seq largely as described (Oosterhof et al., 2017). FAC-sorted microglia were collected
and lysed in RNase-free water containing 0.2% v/v Triton X-100 and RNase inhibitor. PolyA+ RNA was reverse transcribed using an
oligo(dT) primer. Template switching by reverse transcriptase was achieved by using an LNA containing TSO oligo. The reverse-tran-
scribed cDNAwas pre-amplified with primers for 18 cycles followed by clean-up. Tagmentation was performed on 500 pg of the pre-
amplified cDNAwith Tn5 followed by gap repair. The tagmented library was extendedwith Illumina adaptor sequences by PCR for 14
cycles and then purified. The resulting sequencing library was measured on Bioanalyzer and equimolar samples were loaded onto a
flowcell and sequenced according to the Illumina TruSeq v3 protocol on the HiSeq2500 with a single-read 50 bp and dual 9 bp
indices. The sequencing reads were mapped against the GRCz10 zebrafish genome using the HiSat2 aligner (Pertea et al., 2016).
To quantify the aligned and filtered data, the Bioconductor package Genomic Ranges was used (Lawrence et al., 2013). Differential
gene expression analysis was performed using the Bioconductor package edgeR (Robinson et al., 2010). To assess the differenti-
ation status of csf1rmutant microglia, the differential gene expression list was compared with previously publishedmicroglia expres-
sion profiles obtained in zebrafish and mice (Bennett et al., 2016; Matcovitch-Natan et al., 2016; Oosterhof et al., 2017). We used the
Bioconductor tool Biomart to find high-confidence zebrafish orthologs for the genes from studies performed in mice (Durinck et al.,
2009). For gene ontology analysis the Bioconductor package goseq was used (Young et al., 2010).
Electron microscopy
Electron microscopy was performed largely as described previously (van Ham et al., 2014). 4 to 5-month-old zebrafish were eutha-
nized in ice water. The brains were carefully removed and incubated in Zamboni’s fixative (4% PFA, 2% glutaraldehyde, 0.2% picric
acid, 0.1M cacodylate, pH = 7.4) at 4C overnight. Brains were washed in cacodylate (3x5 min) and postfixed in a solution containing
1% osmium tetroxide (OsO4) and 1.5% potassium ferrocyanide (K4Fe(CN)6) on ice for 2 hr. The brains were then washed in milliQ
water (3x5 min) and dehydrated in series of 30%, 50%, 70% ethanol (10 min each), followed by 3 3 20 min incubation in absolute
ethanol. Brains were rinsed in acetone, followed by incubation in a 1:1 EPON:acetone solution overnight. Next, the brains were incu-
bated in pure EPON for 1 hr. New EPON was added followed by incubation in EPON for 2 hr. Samples were put at 200 mbar vacuum
for 30 min at 37C. Polymerization took place at 58C for 3 days. Ultra-thin sections were subsequently cut, collected on formvar-
coated single-slot grids, and stained with a 1% aqueous uranyl acetate solution for 20 min and subsequently for 1 min with lead cit-
rate. Photographs were obtained using a JEOL 1010 electron microscope. For each myelinated axon present the axonal diameter
(defined by the inner limit of themyelin sheath) and total fiber diameter (defined by the outer limit of themyelin sheath) weremeasured
using FIJI and the g-ratio was calculated by dividing the axonal diameter by the total fiber diameter (Camargo et al., 2017). Each group
consisted of two to three zebrafish, and contained at least 240 myelinated fibers per genotype.
QUANTIFICATION AND STATISTICAL ANALYSIS
GraphPad Prism 6 software (La Jolla, CA) was used for statistical tests including one-way ANOVA with Bonferroni multiple testing
correction and data are presented asmean ± SD as indicated. For Figures 1 and 5, quantification was done blinded as larval progenye5 Cell Reports 24, 1203–1217.e1–e6, July 31, 2018
were genotyped after quantification, and sample sizes depend on the –Mendelian- distribution of genotypes. For analysis of adult
brains sample sizes (n = 3-4) are similar to those in previous publications (Oosterhof et al., 2017). A p value smaller than 0.05 was
considered as significant.
DATA AND SOFTWARE AVAILABILITY
The accession number for the gene level RNA-sequencing data from freshly isolated microglia and brain from control and csf1r
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